CD30+ lymphoproliferative disorder following immune checkpoint inhibition in a patient with Merkel cell carcinoma
Open Access
- 21 May 2025
- journal article
- case report
- Published by Elsevier in JAAD Case Reports
- Vol. 62, 50-52
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Ulcerative lymphomatoid papulosis following immune checkpoint inhibition and autologous stem cell transplant in a patient with recurrent Hodgkin lymphoma: a case reportActa Oncologica, 2023
- StatPearls2023
- Etiopathogenesis, Diagnosis, and Treatment Strategies for Lymphomatoid Papulosis with Particular Emphasis on the Role of the Immune SystemCells, 2022
- Lymphomatoid papulosis during immune checkpoint inhibitor treatmentInternational Journal of Hematology, 2022
- CD30+ lymphomatoid skin toxicity secondary to ipilimumabJAAD Case Reports, 2020
- Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)Cochrane Database of Systematic Reviews, 2018
- Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network, 2018
- Merkel cell carcinoma: An update and reviewJournal of the American Academy of Dermatology, 2018
- Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patientsJournal of the American Academy of Dermatology, 2016